FTO and acute myeloid leukemia: It directly binds to FTO protein, inhibits FTO activity, and sensitizes the cells to commonly used chemotherapy agents as well as exerts antileukemia effects through increasing global m6A modification levels in R-2HG-sensitive AML (Su et al., 2018).